Home  >  Products  >  ETF1 (eukaryotic translation termination factor 1) Blocking Peptide (the N terminal of ETF1)(100ug)
ETF1 (eukaryotic translation termination factor 1) Blocking Peptide (the N terminal of ETF1)(100ug)

ETF1 (eukaryotic translation termination factor 1) Blocking Peptide (the N terminal of ETF1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-ETF1 Antibody(ARP54738_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP54738
Size: 100ug
Weight: 49kDa
Gene: 2107
Format: Lyophilized powder
Target: Termination of protein biosynthesis and release of the nascent polypeptide chain are signaled by the presence of an in-frame stop codon at the aminoacyl site of the ribosome. The process of translation termination is universal and is mediated by protein release factors (RFs) and GTP. A class 1 RF recognizes the stop codon and promotes the hydrolysis of the ester bond linking the polypeptide chain with the peptidyl site tRNA, a reaction catalyzed at the peptidyl transferase center of the ribosome. Class 2 RFs, which are not codon specific and do not recognize codons, stimulate class 1 RF activity and confer GTP dependency upon the process. In prokaryotes, both class 1 RFs, RF1 and RF2, recognize UAA; however, UAG and UGA are decoded specifically by RF1 and RF2, respectively. In eukaryotes, eRF1, or ETF1, the functional counterpart of RF1 and RF2, functions as an omnipotent RF, decoding all 3 stop codons (Frolova et al., 1994 [PubMed 7990965]).
Alternative names: D5S1995; ERF; ERF1; MGC111066; RF1; SUP45L1; TB3-1
See Full Product Listings >